857 related articles for article (PubMed ID: 29970026)
1. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.
Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H
BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026
[TBL] [Abstract][Full Text] [Related]
2. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
[TBL] [Abstract][Full Text] [Related]
3. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
[TBL] [Abstract][Full Text] [Related]
4. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
5. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
[TBL] [Abstract][Full Text] [Related]
6. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
[TBL] [Abstract][Full Text] [Related]
7. A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.
Sweeting AN; Wong J; Appelblom H; Ross GP; Kouru H; Williams PF; Sairanen M; Hyett JA
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2122-2130. PubMed ID: 28562122
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
[TBL] [Abstract][Full Text] [Related]
9. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
[TBL] [Abstract][Full Text] [Related]
11. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia.
Andrietti S; Carlucci S; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Aug; 50(2):221-227. PubMed ID: 28078815
[TBL] [Abstract][Full Text] [Related]
12. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
[TBL] [Abstract][Full Text] [Related]
13. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
[TBL] [Abstract][Full Text] [Related]
14. First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia.
Keikkala E; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
Placenta; 2013 Nov; 34(11):1059-65. PubMed ID: 23993394
[TBL] [Abstract][Full Text] [Related]
15. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
Yu N; Cui H; Chen X; Chang Y
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation.
Sapantzoglou I; Wright A; Arozena MG; Campos RV; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):75-83. PubMed ID: 33142353
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
Pihl K; Sørensen S; Stener Jørgensen F
Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
[TBL] [Abstract][Full Text] [Related]
18. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women.
Keikkala E; Forstén J; Ritvos O; Stenman UH; Kajantie E; Hämäläinen E; Räikkönen K; Villa PM; Laivuori H
Pregnancy Hypertens; 2021 Aug; 25():116-122. PubMed ID: 34116346
[TBL] [Abstract][Full Text] [Related]
19. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
Yu J; Shixia CZ; Wu Y; Duan T
Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
[TBL] [Abstract][Full Text] [Related]
20. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 35-37 weeks' gestation.
Sarno M; Wright A; Vieira N; Sapantzoglou I; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Apr; 57(4):600-606. PubMed ID: 33073902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
